Old Web
English
Sign In
Acemap
>
authorDetail
>
John Shepherd
John Shepherd
Utrecht University
Myeloid leukemia
Daunorubicin
Cytarabine
Medicine
Antimetabolite
2
Papers
166
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
status at diagnosis previously untreated acute myeloid leukemia (AML), in relation to MDR1 daunorubicin and cytarabine in the treatment of elderly patients with The value of the MDR1 reversal agent PSC-833 in addition to
2013
Matthias Theobald
Martin F. Fey
Edo Vellenga
Margaret Dugan
Pieter Sonneveld Piccaluga
Gert J. Ossenkoppele
Augustin Ferrant
Michael Crump
Dominik Bronno van der Holt
Bob Lowenberg
Alan K Burnett
Wolfgang Knauf
John Shepherd
Pier P
Show All
Source
Cite
Save
Citations (0)
The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis
2005
Blood
Bronno van der Holt
Bob Löwenberg
Alan K Burnett
Wolfgang Knauf
John Shepherd
Pier Paolo Piccaluga
Gert J. Ossenkoppele
Gregor Verhoef
Augustin Ferrant
Michael Crump
Dominik Selleslag
Matthias Theobald
Martin F. Fey
Edo Vellenga
Margaret Dugan
Pieter Sonneveld
Show All
Source
Cite
Save
Citations (166)
1